Literature DB >> 1444478

CA074 methyl ester: a proinhibitor for intracellular cathepsin B.

D J Buttle1, M Murata, C G Knight, A J Barrett.   

Abstract

The specificity of compound CA074 [N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-pro line] for the inactivation of cathepsin B was quantified in in vitro measurements with cysteine endopeptidases from cattle, it being found that the compound is a very rapid inactivator of cathepsin B (rate constant 112,000 M-1.s-1), with barely detectable action on cathepsins H, L, and S or m-calpain. Conversion of the proline carboxyl group of the inhibitor to the methyl ester virtually abolished the effect on cathepsin B, and a possible explanation for the importance of the carboxyl is presented on the basis of the tertiary structure of cathepsin B. It was found that CA074 methyl ester (1 microM, 3 h) caused selective inactivation of the intracellular cathepsin B of human gingival fibroblasts in culture, in contrast to other available agents, and we suggest that CA074 methyl ester will be of value in the elucidation of the biological functions of cathepsin B.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1444478     DOI: 10.1016/0003-9861(92)90290-d

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  58 in total

1.  Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.

Authors:  V J Chan; P M Selzer; J H McKerrow; J A Sakanari
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.

Authors:  Uma Chandrachud; Mathew W Walker; Alexandra M Simas; Sasja Heetveld; Anton Petcherski; Madeleine Klein; Hyejin Oh; Pavlina Wolf; Wen-Ning Zhao; Stephanie Norton; Stephen J Haggarty; Emyr Lloyd-Evans; Susan L Cotman
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

3.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

Review 4.  Protease pathways in peptide neurotransmission and neurodegenerative diseases.

Authors:  Vivian Y H Hook
Journal:  Cell Mol Neurobiol       Date:  2006-05-25       Impact factor: 5.046

5.  Cigarette smoke condensate increases cathepsin-mediated invasiveness of oral carcinoma cells.

Authors:  Nagathihalli S Nagaraj; Wolfgang Zacharias
Journal:  Toxicol Lett       Date:  2007-03-01       Impact factor: 4.372

6.  A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.

Authors:  Naina Patel; Shekhar Krishnan; Marc N Offman; Marcin Krol; Catherine X Moss; Carly Leighton; Frederik W van Delft; Mark Holland; Jizhong Liu; Seema Alexander; Clare Dempsey; Hany Ariffin; Monika Essink; Tim O B Eden; Colin Watts; Paul A Bates; Vaskar Saha
Journal:  J Clin Invest       Date:  2009-06-08       Impact factor: 14.808

7.  Cathepsin B mediates TRAIL-induced apoptosis in oral cancer cells.

Authors:  Nagathihalli S Nagaraj; Nadarajah Vigneswaran; Wolfgang Zacharias
Journal:  J Cancer Res Clin Oncol       Date:  2005-12-16       Impact factor: 4.553

8.  Genetic and pharmacological evidence implicates cathepsins in Niemann-Pick C cerebellar degeneration.

Authors:  Chan Chung; Prasanth Puthanveetil; Daniel S Ory; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2016-01-28       Impact factor: 6.150

Review 9.  Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling.

Authors:  V Everts; E van der Zee; L Creemers; W Beertsen
Journal:  Histochem J       Date:  1996-04

10.  Cathepsin L Mediates the Degradation of Novel APP C-Terminal Fragments.

Authors:  Haizhi Wang; Nianli Sang; Can Zhang; Ramesh Raghupathi; Rudolph E Tanzi; Aleister Saunders
Journal:  Biochemistry       Date:  2015-04-28       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.